PMO Interview with the Innovator Series: Volume 7

Video Categories: PMO Interview with the Innovator Series

Listen as some of the top academic and community thought leaders in multiple myeloma define what precision medicine means to them.

January 13, 2015

BCI Affects and Survivorship

Dr Susan K. Boolbol talks about the importance of objective evidence provided by the Breast Cancer IndexSM (BCI) in treatment decision making.

March 24, 2015

In Pursuit of Targeted Therapies

As we learn more about a person’s genetic makeup, the more we are able to target medicines to his/her needs and benefit. With continued research, Dr. Stainthorpe explains, we will be able to identify markers that allow us to target medicines more precisely to get better performance and reduce waste.